Clinical Trial Update: Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effects of acarbose and vildagliptin on visceral fat distribution in newly diagnosed type 2 diabetes patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Acarbose (acarbose)
• Vildagliptin (vildagliptin)

Snippet

Sponsor: Peking University | Conditions: Diabetes Mellitus, Type 2, Obesity | Phase 4 | Status: UNKNOWN